[india-drug] IUPHAR World Congress- Australia. More information

[E-drug <e-drug@usa.healthnet.org>]

[Copied from Edrug. Thanks???..SS]

E-drug: IUPHAR World Congress- Australia. More information
---------------------------------------------
[Please respond directly to the website provided or to 
mddah@mail.newcastle.edu.au  NOT to e-drug.  We will collate and 
share e-drug suggestions,  BS]

On Sept 7th Prof Ric Day posted a message on E-Drug requesting
proposals
and suggestions for the scientific program for CPT 2004:  8th IUPHAR 
World Congress on Clinical Pharmacology & Therapeutics 1st-6th August 
2004, Brisbane Australia.

This e-mail is to provide further information about the planning of the
Medicines and Society Stream of CPT2004, which is particularly relevant
to readers of E-Drug.

You are invited to look at the program outline for this stream given
below and make suggestions.  The outline is indicative only, and
suggestions for changes  or additions do not have to conform in any way
with what is laid out.  We will welcome any suggestions for new topics,
no matter how radical they seem.

Proposals can be made at the Web site (http://www.cpt2004.com), but if
you prefer a less formal approach and wish to provide comments or
suggestions please send these to me directly  at
mddah@mail.newcastle.edu.au

Regards to all

David Henry
Professor of Clinical Pharmacology,
Faculty of Health,
The University of Newcastle, NSW
AUSTRALIA
Phone + 61 249 211856
Fax +61 249 602088
David Henry <mddah@mail.newcastle.edu.au>


Outline of Program---------------------------------------

CPT 2004
MEDICINES AND SOCIETY STREAM
Candidate topics for symposia/plenaries

QUALITY USE OF MEDICINES
Curriculum development
Undergraduate education
Prescriber interventions
Feedback programs
National Prescribing Service
Community/consumer interventions
QUM in children (including issues relating to equity of access; trying
to
promote "EBP" when the "E" is so scant in many areas of pediatric
therapeutics etc etc)

DRUG INFORMATION
Evidence-based sources - focus on disease rather than drug-specific
information
Decision support
Independent journals
Bulletins in developing countries
Direct to consumer information

DRUG UTILISATION
Computerised prescribing
Prescribing linkage - diagnostics, indications, outcomes
Development of prescribing indicators
IT developments

ACCESS TO MEDICINES
WHO Essential Drugs Program
National Medicinal Drug Policies
Patents/TRIPS/prices
Production quality/dealing with counterfeits
Non-prescription medicines in developing and developed countries
Franchising of essential drugs

PHARMACO-ECONOMICS AND DRUG SELECTION
Who should make decisions?
Beyond cost-effectiveness - what other factors should be included?
Use of CE data in price negotiations
Experience of decision making in different jurisdictions

DRUG REGULATION/EVALUATION
Focus on issues in children: lack of data on safety and efficacy;
developments in Europe and USA, controversies and lessons
Pre peri and post-natal issues
Delayed publication of key data on safety and efficacy

MEDICATION SAFETY AND PHARMACOVIGILANCE
Country activities - international developments
Methodological developments
Complementary medicines
Identifying and quantifying ADRs in children
Systematic reviews
Access to national and international data-bases

SOUTH-NORTH TECHNOLOGY TRANSFER: HOW RICH COUNTRIES CAN LEARN FROM THE
POOR
Examples of work done primarily in developing countries that has been
(or could be) transferred to the developed world
MgS04 and PET
Artemesian derivatives in malaria
Techniques for improving drug use at a community level
Management of organophosphate poisoning
What can be done to improve transfer of drug knowledge in both
directions?

[The original message can be found on e-drug archives.  BS]
 


________________________________________________________________________
Missed your favourite TV serial last night? Try the new, Yahoo! TV.
       visit http://in.tv.yahoo.com
The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@usa.healthnet.org